Balancing Farm Life and Diabetes: A Family’s Battle against High Insulin Costs

Balancing Farm Life and Diabetes: A Family’s Battle against High Insulin Costs

The Kritzberger family’s farm in the Red River Valley has been in operation for more than a century. They once raised livestock but now focus on cultivating sugar beets, soybeans, and grains. Like many in agriculture, managing finances is challenging. “We’re in an incredible amount of debt,” stated Ang Kritzberger during a recent walk on the farm.

In addition to financial struggles, for over a decade, the Kritzbergers have dealt with another issue. Their daughter, Nina, lives with Type 1 diabetes, situating them in a national conversation about insulin costs. Nina was diagnosed at age 7, prompting Ang to keep a vigilant watch over her at night, checking her blood sugar every two hours. Despite having insurance, they pay over $8,000 out-of-pocket annually for Nina’s medical care.

The rising cost of insulin has forced many to limit their use, sometimes with fatal outcomes. However, efforts to limit what people with diabetes pay for insulin have gained momentum. Democrats and Republicans are uniting over the shared goal to curb drug costs. North Dakota state Sen. Sean Cleary remarked on the bipartisan agreement over flawed market conditions impacting insulin prices.

Cleary co-sponsored a bill to cap insulin costs at $25 a month in North Dakota, joining 29 states with similar measures. These caps intend to lower out-of-pocket expenses for patients even with high deductibles. Patient advocates pushed for protections as insulin costs soared; federal data show out-of-pocket costs peaked at $470 annually in 2018 before falling to $220 by 2025.

For families like the Kritzbergers, these price caps provide some security amid chronic disease management. Nina Kritzberger, now 17, frequently makes provisions for her diabetes care, ensuring she has the necessary equipment and supplies.

The idea of insulin price caps started with Democrats. Colorado led the way in 2019, restricting state-regulated plans from charging more than $100 for a month’s supply. In 2022, President Biden set a $35 monthly cap for Medicare enrollees. Efforts to extend caps to private insurance were stifled by Republican opposition.

In North Dakota, state Sen. Tim Mathern struggled to gain support for insulin caps. The small Democratic presence and convincing health insurers of the benefits was a significant challenge. Insurers argued that mandates could raise premiums. YYet, advocates highlighted successes with similar caps for state employees, showcasing minimal premium impacts.

Ang and Nina Kritzberger joined others in advocating at the Capitol. Ang felt daunted but determined in the face of opposing testimony. Frustration with the healthcare market’s failures drove the legislation forward. Many lawmakers shared disbelief over high costs for a century-old drug.

State Rep. Carrie McLeod, a diabetes educator, criticized the shift in health insurance focus away from patient care. These assurances help families avoid impossible choices about healthcare spending.

Despite limitations, state regulations signal growing support for healthcare price oversight. A KFF survey reflected bipartisan agreement on the need for governmental control over drug prices. Congress is evaluating a national insulin price cap.

Reflecting on the journey, Ang Kritzberger emphasized the support network within North Dakota. “It’s about finding common ground,” she said, highlighting community bonds in times of need.

This article is a product of KFF Health News, focusing on health journalism, and is shared under a Creative Commons License. Learn more about KFF at their website.

Leave a Reply

Your email address will not be published. Required fields are marked *